Is ATTO or INMD more profitable?

INMD runs the higher net margin — ATTO at -4490.89% versus INMD at 20.69%.

Attovia Therapeutics, Inc. (ATTO) vs InMode Ltd. (INMD)

A side-by-side comparison of Attovia Therapeutics, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATTO

Attovia Therapeutics, Inc.

$761M

$17.68HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

INMD

InMode Ltd.

$804M

$13.99HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

Total return — ATTO vs INMD

growth of $100 · dividends reinvested · last 1y

ATTO -17.8% (-17.8%/yr)INMD -7.1% (-7.1%/yr)INMD compounded faster over this window

ATTO INMD

ATTO vs INMD: by the numbers

•INMD is the larger company ($804M vs $761M market cap).
•INMD is profitable (20.69% net margin) while ATTO runs a net loss (-4490.89%).

Metrics side by side

Valuation

Metric	ATTO	INMD
P/E ratio	N/A	11.37
Forward P/E	N/A	10.79
PEG ratio	N/A	1.14
P/S ratio	N/A	2.15
P/B ratio	N/A	1.28
EV / EBITDA	N/A	5.90
FCF yield	N/A	10.88%

Profitability

Metric	ATTO	INMD
Gross margin	40.44%	76.52%
Operating margin	-4974.74%	18.47%
Net margin	-4490.89%	20.69%
ROE	-40.21%	12.32%
ROIC	-42.83%	9.20%

Growth (annualized)

Metric	ATTO	INMD
Revenue CAGR (5Y)	N/A	5.42%
EPS CAGR (5Y)	N/A	6.87%
FCF CAGR (5Y)	N/A	1.36%
Total return CAGR (5Y)	N/A	-27.48%

Frequently asked

Is ATTO or INMD more profitable?: INMD runs the higher net margin — ATTO at -4490.89% versus INMD at 20.69%.

Go deeper

Full ATTO analysis Full INMD analysis Interactive comparison tool

Dig into the metrics

InMode P/E ratio Attovia Therapeutics ROE InMode ROE Attovia Therapeutics operating margin InMode operating margin Attovia Therapeutics revenue growth InMode revenue growth Attovia Therapeutics free cash flow InMode free cash flow

Attovia Therapeutics & InMode appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.